20. Yang H, Landis-Piwowar K, Chan T, Dou QP (2011) Green tea polyphenols as proteasome inhibitors: implication in chemoprevention. Curr Cancer Drug Targets 11: 296–306. 21. Yang H, Landis-Piwowar KR, Chen D, Milacic V, Dou QP (2008) Natural compounds with proteasome inhibitory activity for cancer prevention and treatment. Curr Protein Pept Sci 9: 227–239. 22. Mullally JE, Moos PJ, Edes K, Fitzpatrick FA (2001) Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway. J Biol Chem 276: 30366–30373. 23. Verbitski SM, Mullally JE, Fitzpatrick FA, Ireland CM (2004) Punaglandins, chlorinated prostaglandins, function as potent Michael receptors to inhibit ubiquitin isopeptidase activity. J Med Chem 47: 2062–2070. 24. Colland F (2010) The therapeutic potential of deubiquitinating enzyme inhibitors. Biochem Soc Trans 38: 137–143. 25. Daviet L, Colland F (2008) Targeting ubiquitin specific proteases for drug discovery. Biochimie 90: 270–283. 26. Luker GD, Pica CM, Song J, Luker KE, Piwnica-Worms D (2003) Imaging 26S proteasome activity and inhibition in living mice. Nat Med 9: 969–973. 27. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1: 2315–2319. 28. Chou TC, Talalay P (1984) Quantitative analysis of dose-effect relashionship: the combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulations 22: 27–55. 29. Bjorklund M, Roos J, Gogvadze V, Shoshan M (2011) Resveratrol induces SIRT1- and energy-stress-independent inhibition of tumor cell regrowth after low-dose platinum treatment. Cancer Chemother Pharmacol;DOI 10.1007/ s00280-011-1640-x. 30. Ganapathy S, Chen Q, Singh KP, Shankar S, Srivastava RK (2010) Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor. PLoS One 5: e15627. 31. Lee JH, Kishikawa M, Kumazoe M, Yamada K, Tachibana H (2010) Vitamin A enhances antitumor effect of a green tea polyphenol on melanoma by upregulating the polyphenol sensing molecule 67-kDa laminin receptor. PLoS One 5: e11051. Causing UPS Stress for Cervical Cancer Treatment 32. Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H (2006) Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 66: 2500–2505. 33. Belguise K, Guo S, Yang S, Rogers AE, Seldin DC, et al. (2007) Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype. Cancer Res 67: 11742–11750. 34. Belguise K, Guo S, Sonenshein GE (2007) Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. Cancer Res 67: 5763–5770. 35. Xiao XY, Hao M, Yang XY, Ba Q, Li M, et al. (2011) Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis. Cancer Lett 302: 69–75. 36. Jing H, Zhou X, Dong X, Cao J, Zhu H, et al. (2010) Abrogation of Akt signaling by Isobavachalcone contributes to its anti-proliferative effects towards human cancer cells. Cancer Lett 294: 167–177. 37. Driscoll JJ, Dechowdhury R (2010) Therapeutically targeting the SUMOylation, Ubiquitination and Proteasome pathways as a novel anticancer strategy. Target Oncol 5: 281–289. 38. Baldisserotto A, Destro F, Vertuani G, Marastoni M, Gavioli R, et al. (2009) N- terminal-prolonged vinyl ester-based peptides as selective proteasome beta1 subunit inhibitors. Bioorg Med Chem 17: 5535–5540. 39. Nawrocki ST, Carew JS, Pino MS, Highshaw RA, Andtbacka RH, et al. (2006) Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells. Cancer Res 66: 3773–3781. 40. Rocha S, Martin AM, Meek DW, Perkins ND (2003) p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1. Mol Cell Biol 23: 4713–4727. 41. Masamha CP, Benbrook DM (2009) Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells. Cancer Res 69: 6565–6572. PLoS ONE | www.plosone.org 10 August 2011 | Volume 6 | Issue 8 | e23888